---
document_datetime: 2024-10-11 09:36:42
document_pages: 14
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/erelzi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: erelzi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 8.2092994
conversion_datetime: 2025-12-27 16:29:01.976766
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Erelzi

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                      | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0056               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)           | 10/10/2024                          |                                             | Labelling and PL                 |           |
| IB/0055              | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation | 07/10/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0054             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                        | 16/08/2024   |            | SmPC and PL   |                                                                                                                        |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------|------------------------------------------------------------------------------------------------------------------------|
| IA/0053             | B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material                                                                                                                                                                                                                                                                                                                          | 25/07/2024   | n/a        |               |                                                                                                                        |
| IA/0052/G           | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised | 16/04/2024   | n/a        |               |                                                                                                                        |
| IB/0051             | B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                             | 29/02/2024   | n/a        |               |                                                                                                                        |
| PSUSA/10795 /202302 | Periodic Safety Update EU Single assessment - etanercept                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 12/10/2023   | 11/12/2023 |               | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for |

<div style=\"page-break-after: always\"></div>

|             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |            |                                  | PSUSA/10795/202302.   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------|
| IB/0050     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 08/12/2023 |            | SmPC, Annex II, Labelling and PL |                       |
| IB/0048     | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 07/08/2023 | n/a        |                                  |                       |
| IAIN/0049/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer | 01/08/2023 | 11/12/2023 | Annex II and PL                  |                       |

<div style=\"page-break-after: always\"></div>

|           | Not including batch control/testing A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)     |            |     |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0046/G | This was an application for a group of variations. B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition) | 04/05/2023 | n/a |

<div style=\"page-break-after: always\"></div>

| IB/0045   | B.II.c.z - Change in control of excipients in the Finished Product - Other variation                                                                                                                                                                                                                                                                                                                                                                               | 17/02/2023   | n/a        |             |                                                                                                                                                                                                                                                                                                           |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0043   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                       | 08/09/2022   | 17/07/2023 | SmPC and PL |                                                                                                                                                                                                                                                                                                           |
| II/0042/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.e.1.b.2 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Sterile medicinal products and biological/immunological medicinal products                                                                                                                                                    | 21/07/2022   | 17/07/2023 | SmPC and PL | The SmPC section 6.5 has been updated to include the new syringe, autoinjector and describe the needle shield. Editorial changes are also made to section 3, pharmaceutical form, of the SmPC to bring it in line with the current QRD template version. The Package Leaflet (PL) is updated accordingly. |
| WS/2271/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other | 21/07/2022   | n/a        |             |                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|           | or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                      |            |            |                                  |                                                                                                                                                                                                                                                                      |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0040/G | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.4.e - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of an in-process test which may have a significant effect on the overall quality of the AS                   | 21/07/2022 | n/a        |                                  |                                                                                                                                                                                                                                                                      |
| IA/0039   | B.II.d.2.b - Change in test procedure for the finished product - Deletion of a test procedure if an alternative method is already authorised                                                                                                                                                                                                                                     | 20/04/2022 | n/a        |                                  |                                                                                                                                                                                                                                                                      |
| R/0037    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                          | 27/01/2022 | 04/04/2022 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Erelzi in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| II/0038/G | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal | 13/01/2022 | n/a        |                                  |                                                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

|             | product and is not related to a protocol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |             |         |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------|
| IB/0036     | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                        | 24/06/2021 | n/a        |             |         |
| IB/0035/G   | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 12/05/2021 | 19/10/2021 | SmPC and PL | the MAH |
| IB/0034     | B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line)                                                                                                                                                                                                                                                                                                                                    | 18/02/2021 | n/a        |             |         |
| IAIN/0033/G | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.3.a - Change(s) in the SPC, Labelling or PL                                                                                                                                                                                                                                                                                                                                                                    | 30/10/2020 | 19/10/2021 | SmPC and PL |         |

<div style=\"page-break-after: always\"></div>

|                     | intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Implementation of wording agreed by the competent authority                                                                                                                     |            |            |                                  |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| IB/0032             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                   | 09/10/2020 | 19/10/2021 | SmPC, Annex II, Labelling and PL |                                   |
| PSUSA/10795 /202002 | Periodic Safety Update EU Single assessment - etanercept                                                                                                                                                                                                                                                       | 03/09/2020 | n/a        |                                  | PRAC Recommendation - maintenance |
| IAIN/0031           | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                             | 28/08/2020 | n/a        |                                  |                                   |
| IB/0030             | B.I.e.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product                                                                                                                                                                    | 03/08/2020 | 30/09/2020 | Annex II                         |                                   |
| IB/0029/G           | This was an application for a group of variations. B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol B.II.f.1.e - Stability of FP - Change to an approved stability protocol | 15/07/2020 | 30/09/2020 | SmPC                             |                                   |

<div style=\"page-break-after: always\"></div>

| IA/0028   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 12/06/2020   | n/a   |                 |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------|
| IAIN/0026 | C.I.11.a - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of wording agreed by the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 10/04/2020   | n/a   |                 |
| IA/0025   | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 18/03/2020   | n/a   |                 |
| II/0024/G | This was an application for a group of variations. B.I.a.1.j - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Replacement or addition of a site where batch control/testing takes place and any of the test method at the site is a biol/immunol method B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.II.b.2.z - Change to importer, batch release arrangements and quality control testing of the FP - Other variation B.II.b.2.z - Change to importer, batch release arrangements and quality control testing of the FP - | 12/03/2020   | n/a   | Other variation |

<div style=\"page-break-after: always\"></div>

| IB/0022             | B.IV.1.z - Change of a measuring or administration device - Other variation                                                                                                                                                                                  | 28/01/2020   | n/a        |                                  |                                                                                                                                                                                |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0023             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                             | 12/12/2019   | n/a        |                                  |                                                                                                                                                                                |
| PSUSA/10452 /201901 | Periodic Safety Update EU Single assessment - etanercept (biosimilars)                                                                                                                                                                                       | 19/09/2019   | 14/11/2019 | SmPC and PL                      | Please refer to Benepali Erelzi EMEA/H/C/PSUSA/00010452/201901 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation |
| IB/0021             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 08/10/2019   | 30/09/2020 | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                |
| II/0018             | B.I.e.2 - Introduction of a post approval change management protocol related to the AS                                                                                                                                                                       | 26/09/2019   | n/a        |                                  |                                                                                                                                                                                |
| IA/0020             | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                             | 14/06/2019   | n/a        |                                  |                                                                                                                                                                                |
| IB/0019             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by         | 16/05/2019   | 14/11/2019 | SmPC, Labelling and PL           |                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

|                     | the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |            |     |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IA/0017             | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                       | 10/05/2019 | n/a |                                   |
| IB/0015             | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                                                                                                                                           | 12/04/2019 | n/a |                                   |
| IA/0014/G           | This was an application for a group of variations. B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.III.2.c - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change in specifications from a national pharmacopoeia of a | 28/03/2019 | n/a |                                   |
| IB/0013             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                    | 19/02/2019 | n/a |                                   |
| PSUSA/10452 /201807 | Periodic Safety Update EU Single assessment - etanercept (biosimilars)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 14/02/2019 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IA/0012             | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                                                                                                                                                                                                                             | 04/01/2019   | n/a   |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| PSUSA/10452 /201801 | Periodic Safety Update EU Single assessment - etanercept (biosimilars)                                                                                                                                                                                                                                                                                                                                                                                                 | 06/09/2018   | n/a   | PRAC Recommendation - maintenance |
| IA/0010             | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                   | 04/09/2018   | n/a   |                                   |
| IB/0009/G           | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method | 30/07/2018   | n/a   |                                   |
| IB/0008/G           | This was an application for a group of variations. B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.a.4.c - Change to in-process tests or limits                                                                                                                                             | 30/05/2018   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|           | applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                                               |            |            |             |         |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------|
| IB/0006   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                        | 28/03/2018 | 11/07/2018 | SmPC and PL |         |
| II/0005/G | This was an application for a group of variations. B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing processes B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished - Other variation | 01/02/2018 | n/a        |             | product |

<div style=\"page-break-after: always\"></div>

| IB/0004   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                             | 17/11/2017   | 11/07/2018   | SmPC and PL            |                  |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|------------------|
| IB/0003   | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                             | 10/10/2017   | n/a          |                        |                  |
| IB/0002/G | This was an application for a group of variations. B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test                                                                                                                                                                | 10/10/2017   | n/a          |                        |                  |
| IB/0001/G | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside currently approved pack sizes | 28/07/2017   | 11/07/2018   | SmPC, Labelling and PL | the range of the |